Literature DB >> 21189327

MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.

Kouhei Sakurai1, Chihiro Furukawa, Takeshi Haraguchi, Ken-ichi Inada, Kazuya Shiogama, Takanobu Tagawa, Shuji Fujita, Yoshihito Ueno, Aya Ogata, Mai Ito, Yutaka Tsutsumi, Hideo Iba.   

Abstract

The chromatin remodeling complex SWI/SNF is an important epigenetic regulator that includes one Brm or BRG1 molecule as catalytic subunit. Brm and BRG1 do not function identically, so this complex can regulate gene expression either positively or negatively, depending on the promoter to which it is recruited. Notably, Brm attenuation due to posttranscription suppression occurs often in human tumor cells, in which this event contributes to their oncogenic potential. Here, we report that the 3'-untranslated region of Brm mRNA has two sites that are efficiently targeted by the microRNAs miR-199a-5p and -3p, revealing a novel mechanism for modulation of Brm-type SWI/SNF activity. Computational mapping of the putative promoter region of miR-199a-2 (miPPR-199a-2) has defined it as the major contributing genetic locus for miR-199a-5p and-3p production in these tumor cell lines. We validated this predicted region by direct promoter analysis to confirm that Egr1 is a strong positive regulator of the miR-199a-2 gene. Importantly, we also showed that Egr1, miR-199a-5p, and miR-199a-3p are expressed at high levels in Brm-deficient tumor cell lines but only marginally in Brm-expressing tumor cells. Finally, we also obtained evidence that Brm negatively regulates Egr1. Together, our results reveal that miR-199a and Brm form a double-negative feedback loop through Egr1, leading to the generation of these two distinct cell types during carcinogenesis. This mechanism may offer a partial explanation for why miR-199a-5p and -3p have been reported to be either upregulated or downregulated in a variety of tumors. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189327     DOI: 10.1158/0008-5472.CAN-10-2345

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  58 in total

1.  Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.

Authors:  Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Authors:  Karina A Galoian; Toumy Guettouche; Biju Issac; Amir Qureshi; H T Temple
Journal:  Tumour Biol       Date:  2013-11-01

Review 3.  Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.

Authors:  Carolina M Greco; Gianluigi Condorelli
Journal:  Nat Rev Cardiol       Date:  2015-05-12       Impact factor: 32.419

4.  Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers.

Authors:  W M Chatila; G J Criner; W W Hancock; T Akimova; B Moldover; J-K Chang; W Cornwell; M Santerre; T J Rogers
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

5.  Maternal diet-induced microRNAs and mTOR underlie β cell dysfunction in offspring.

Authors:  Emilyn U Alejandro; Brigid Gregg; Taylor Wallen; Doga Kumusoglu; Daniel Meister; Angela Chen; Matthew J Merrins; Leslie S Satin; Ming Liu; Peter Arvan; Ernesto Bernal-Mizrachi
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

6.  miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.

Authors:  Jiwei Huang; BaiJun Dong; Jin Zhang; Wen Kong; Yonghui Chen; Wei Xue; Dongming Liu; Yiran Huang
Journal:  Tumour Biol       Date:  2014-03-09

7.  MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.

Authors:  Guo-Jun Geng; Ying-Tao Yang; Jie Jiang; Xiu-Yi Yu; Xian-En Fa
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

8.  Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

Authors:  Keita Uchino; Fumitaka Takeshita; Ryou-U Takahashi; Nobuyoshi Kosaka; Kae Fujiwara; Haruna Naruoka; Satoru Sonoke; Junichi Yano; Hideo Sasaki; Shiari Nozawa; Miki Yoshiike; Kazuki Kitajima; Tatsuya Chikaraishi; Takahiro Ochiya
Journal:  Mol Ther       Date:  2013-01-08       Impact factor: 11.454

9.  Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma.

Authors:  Aparna Kailasam; Sumeet K Mittal; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-11-12       Impact factor: 4.689

10.  Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.

Authors:  Li Chen; Ruju Chen; Victoria M Velazquez; David R Brigstock
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.